Michael Liberman

Title: Michael Liberman: Innovator in Antibacterial Agents

Introduction

Michael Liberman is a notable inventor based in Redhill, GB. He has made significant contributions to the field of antibacterial agents, particularly through his innovative work on amine salts of clavulanic acid. His research has the potential to impact the medical community by providing new solutions for bacterial infections.

Latest Patents

Michael Liberman holds a patent for "Amine salts of clavulanic acid as antibacterial agents." This invention provides the salts of the formula (II), wherein R¹ is a hydrogen atom or a lower alkyl, aralkyl, phenyl, or inertly substituted lower alkyl, aralkyl, or phenyl group. R² is similarly defined, and R³ is a lower alkyl, aralkyl, phenyl, or inertly substituted lower alkyl, aralkyl, or phenyl group. Any of these groups R¹, R², and R³ may be optionally interlinked to form a ring of 5-7 ring atoms. The compounds developed through this patent are designed to serve as effective antibacterials.

Career Highlights

Michael Liberman is associated with Beecham Group Plc, where he has been instrumental in advancing research in antibacterial agents. His work has contributed to the development of new pharmaceutical solutions that address pressing health concerns.

Collaborations

Michael has collaborated with Kenneth T Veal, working together to enhance the effectiveness of their research and innovations in the field of antibacterial agents.

Conclusion

Michael Liberman's contributions to antibacterial research through his patent on amine salts of clavulanic acid highlight his role as an innovator in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.